npj Journals

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

npj Journals
Jul 15, 2024, 02:10 | Blog
Mammary Cell News congratulates Drs. Carlos Ronchi, Cathrin Brisken on recent NPJ Journals study
Cathrin Brisken, Professor at The Institute of Cancer Research, shared a post by Mammary Cell…
May 26, 2024, 06:31 | Insight
Vivek Subbiah: Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma
Vivek Subbiah shared a post on X/Twitter: "Impressive response to dabrafenib, trametinib, and osimertinib in a…
Apr 20, 2024, 14:18 | Blog
Elisa Agostinetto: The proportion of patients with an actionable alteration (AA) in serial cfDNA decreases with time
Elisa Agostinetto, Clinical Research Fellow at Jules Bordet Institute in Brussels, shared a post on…
Apr 20, 2024, 06:08 | Insight
David Planchard: Some advances for our BRAF V600E NSCLC patients…Review to read at npj Journals
David Planchard, Professor at the University of Paris-Saclay, posted on X/Twitter: "Some advances for our BRAF…
Apr 15, 2024, 09:43 | Blog
Yael Bar: The utility of serial cfDNA analysis in detecting newly emerged actionable alterations in MBC is out in NPJ Journals
Yael Bar, Research fellow at MGH Breast Oncology, shared a post on X: "Our work…
Apr 10, 2024, 05:00 | Blog
Paolo Tarantino: Our study on the prognosis of small TNBCs is out in NPJ Journals
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "Our study…
Mar 29, 2024, 06:30 | Insight
Elisa Agostinetto: Important meta-analysis in NPJ Journals Breast shedding light on one of the biggest unmet needs in breast oncology
Elisa Agostinetto, Medical Oncologist and Research Fellow at Jules Bordet Institute in Brussels, posted on…
Jan 28, 2024, 18:29 | Blog
Elisa Agostinetto: Estradiol levels remain the biomarker of choice
Elisa Agostinetto, Clinical Research Fellow at the Institute Jules Bordet, recently shared on X/Twitter: "Out…
All: 8 Posts: 1 - 100
Special Coverage